Assems Inc. (KOSDAQ:136410)
South Korea · Delayed Price · Currency is KRW 7,610.00
+110.00 (1.47%)
At close: Mar 27, 2026
Assems Revenue
Assems had revenue of 15.11B KRW in the quarter ending September 30, 2025, with 1.67% growth. This brings the company's revenue in the last twelve months to 62.19B, up 14.92% year-over-year. In the year 2024, Assems had annual revenue of 57.17B with 19.78% growth.
Revenue (ttm)
62.19B
Revenue Growth
+14.92%
P/S Ratio
1.34
Revenue / Employee
655.14M
Employees
92
Market Cap
80.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 57.17B | 9.44B | 19.78% |
| Dec 31, 2023 | 47.73B | -5.32B | -10.02% |
| Dec 31, 2022 | 53.05B | 11.03B | 26.23% |
| Dec 31, 2021 | 42.03B | 7.98B | 23.43% |
| Dec 31, 2020 | 34.05B | -63.40M | -0.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Woowon Development | 379.63B |
| Cosmax Nbt | 287.48B |
| Jeil M&S | 202.36B |
| JUNGDAWN | 160.88B |
| Wysiwyg Studios | 106.13B |
| Tplex | 93.85B |
| Icure Pharmaceutical Incorporation | 93.22B |
| HS Valve | 84.43B |